Benzyl (S,S,S)-2-azabicyclo octane-3-carboxylate hydrochloride (CAS NO : 87269-87-2)

Benzyl (S,S,S)-2-azabicyclo[3.3.0]octane-3-carboxylate hydrochloride (CAS No: 87269-87-2) is a critical chiral building block extensively utilized by North American pharmaceutical manufacturers for the asymmetric synthesis of Ramipril, where precise (S,S,S) stereochemistry is vital to the therapeutic efficacy of the final ACE inhibitor. As the prevalence of hypertension and cardiovascular conditions continues to rise across the united states region, domestic API producers require a steady, high-volume supply of this bicyclic heterocyclic precursor, driving the shift toward advanced process chemistry and sustainable synthesis methods to maximize yields and atom economy. With the FDA and other regulatory bodies intensifying oversight on isomeric purity and genotoxic impurities, U.S. procurement teams are increasingly prioritizing suppliers who provide comprehensive analytical dossiers and maintain rigorous quality management systems within the pharmaceutical supply chain. As an established global supplier of Benzyl (S,S,S)-2-azabicyclo octane-3-carboxylate hydrochloride with >= 99% purity, we ensure minimal impurity carry-over in final API production and offer a diverse portfolio of pharmaceutical intermediates for manufacturers and formulators. We provide full analytical support, including HPLC, NMR, and MS data, along with region-specific regulatory documentation such as CoA, TDS, and SDS. Our commitment to the U.S. market includes reliable lead times, technical expertise in scale-up and process optimization, and robust logistics capabilities to support nationwide distribution across all 50 states.